CardieX Limited (CDEX)

CardieX Income Statement

Financials in millions USD. Fiscal year is July - June.

Year Ending	TTM	Jun 30, 2022	Jun 30, 2021
Revenue	3.21	3.97	4.55
Revenue Growth (YoY)	-	-12.87%	-
Cost of Revenue	-	0.71	0.68
Gross Profit	2.66	3.26	3.88
Selling, General & Admin	-	7	4.48
Research & Development	-	2.81	1.31
Other Operating Expenses	0	2.72	2.63
Operating Expenses	-	12.54	8.42
Operating Income	-9.71	-8.57	-3.87
Interest Expense / Income	0.15	0.17	0.2
Other Expense / Income	-0.15	-0.17	-0.2
Pretax Income	-9.71	-8.57	-3.87
Net Income	-9.71	-8.57	-3.87
Free Cash Flow	-6.49	-6.96	-3.25
Gross Margin	82.91%	82.23%	85.16%
Operating Margin	-302.96%	-216.00%	-84.96%
Profit Margin	-302.96%	-216.00%	-84.96%
Free Cash Flow Margin	-202.37%	-175.33%	-71.28%
EBITDA	-9.56	-8.41	-3.67
EBITDA Margin	-298.32%	-211.82%	-80.57%
EBIT	-9.56	-8.41	-3.67
EBIT Margin	-298.32%	-211.82%	-80.57%

Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).